BSL3 and BSL4 agents: Proteomics, glycomics and antigenicity

Jiri Stulik; Rudolf Toman; Patrick Butaye; Robert G. Ulrich

doi:10.1002/9783527638192

BSL3 and BSL4 agents: Proteomics, glycomics and antigenicity

Jiri Stulik, Rudolf Toman, Patrick Butaye, Robert G. Ulrich

Research output: Scholarly Books, Monographs, Reports and Case Studies › RGC 11 - Research book or monograph (Author) › peer-review

Abstract

Unique coverage of proteomic and glycomic approaches to better distinguish highly dangerous pathogens, as well as using these to explore novel treatment and prevention options. The editors and authors are either part of a specialized European network initiated to develop fast and reliable detection and therapy options, or are associated with the core military research complex of the United States. With its description of the methods, their advantages and limitations, as well as the principle outcomes, this is a must-have resource for all professionals dealing with BSL3 and/or BSL 4 agents. © 2011 Wiley-VCH Verlag & Co. KGaA. All rights reserved.

Original language	English
Publisher	Wiley
ISBN (Print)	9783527638192, 9783527327805
DOIs	https://doi.org/10.1002/9783527638192
Publication status	Published - 30 Sept 2011
Externally published	Yes

Bibliographical note

Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].

Access Output

10.1002/9783527638192

Other Access Options

Check CityUHK Library

Permanent Link

Right click to copy link

Cite this

@book{67d5539e59ec4141947c543c67c75edd,

title = "BSL3 and BSL4 agents: Proteomics, glycomics and antigenicity",

abstract = "Unique coverage of proteomic and glycomic approaches to better distinguish highly dangerous pathogens, as well as using these to explore novel treatment and prevention options. The editors and authors are either part of a specialized European network initiated to develop fast and reliable detection and therapy options, or are associated with the core military research complex of the United States. With its description of the methods, their advantages and limitations, as well as the principle outcomes, this is a must-have resource for all professionals dealing with BSL3 and/or BSL 4 agents. {\textcopyright} 2011 Wiley-VCH Verlag & Co. KGaA. All rights reserved.",

author = "Jiri Stulik and Rudolf Toman and Patrick Butaye and Ulrich, {Robert G.}",

note = "Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].",

year = "2011",

month = sep,

day = "30",

doi = "10.1002/9783527638192",

language = "English",

isbn = "9783527638192",

publisher = "Wiley",

}

TY - BOOK

T1 - BSL3 and BSL4 agents

T2 - Proteomics, glycomics and antigenicity

AU - Stulik, Jiri

AU - Toman, Rudolf

AU - Butaye, Patrick

AU - Ulrich, Robert G.

N1 - Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].

PY - 2011/9/30

Y1 - 2011/9/30

N2 - Unique coverage of proteomic and glycomic approaches to better distinguish highly dangerous pathogens, as well as using these to explore novel treatment and prevention options. The editors and authors are either part of a specialized European network initiated to develop fast and reliable detection and therapy options, or are associated with the core military research complex of the United States. With its description of the methods, their advantages and limitations, as well as the principle outcomes, this is a must-have resource for all professionals dealing with BSL3 and/or BSL 4 agents. © 2011 Wiley-VCH Verlag & Co. KGaA. All rights reserved.

AB - Unique coverage of proteomic and glycomic approaches to better distinguish highly dangerous pathogens, as well as using these to explore novel treatment and prevention options. The editors and authors are either part of a specialized European network initiated to develop fast and reliable detection and therapy options, or are associated with the core military research complex of the United States. With its description of the methods, their advantages and limitations, as well as the principle outcomes, this is a must-have resource for all professionals dealing with BSL3 and/or BSL 4 agents. © 2011 Wiley-VCH Verlag & Co. KGaA. All rights reserved.

UR - http://www.scopus.com/inward/record.url?scp=105008488475&partnerID=8YFLogxK

UR - https://www.scopus.com/record/pubmetrics.uri?eid=2-s2.0-105008488475&origin=recordpage

U2 - 10.1002/9783527638192

DO - 10.1002/9783527638192

M3 - RGC 11 - Research book or monograph (Author)

SN - 9783527638192

SN - 9783527327805

BT - BSL3 and BSL4 agents

PB - Wiley

ER -

BSL3 and BSL4 agents: Proteomics, glycomics and antigenicity

Abstract

Bibliographical note

Access Output

Other Access Options

Permanent Link

Other Files and Links

Fingerprint

Cite this